Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE)

Main Article Content

Marjolein de Bruin-Weller
Diamant Thaci
Catherine Smith
Allen Radin
Rick Zhang
Bolanle Akinlade
Abhijit Gadkari
Laurent Eckert
Thomas Hultsch
Gianluca Pirozzi
Neil MH Graham
Brad Shumel

Keywords

atopic dermatitis, refractory, dupilumab, corticosteroid, biologic therapy, clinical trial

Abstract

Abstract Not Available